Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for infant bronchiolitis
ACTRN12615000590561Phase 2Withdrawn
- Sponsor
- Kids Research Institute Australia
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchiolitis comparing Nitazoxanide with Placebo (2 arms). Primary endpoint: Severity of respiratory distress. Planned start Jan 2017; status: withdrawn.
02
Drugs
nitazoxanide
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on ACTRN12615000590561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000590561.